Here is one that I HAVE owned in the past but unfortunately no longer own. APPX today is up strongly at $37.39, a $4.13 gain or 12.42%.
According to CNN.money, American Pharmaceutical partners, Inc., "is a specialty pharmaceutical company that develops, manufactures & markets injectable pharmaceutical products, with a primary focus in the areas of oncology, infectious disease and critical care."
This stock literally exploded on the upside today due to a news report on a "76% response rate in head and neck cancer, 49% response rate in patients with squamous cell anal cancer, and an 80% response rate in patients with uterine carcinoma" with "high dose ABI-007" (no relation to the spy), "a novel cremophor-free protein engineered nanoparticle paclitaxel". Now that you understand THAT....
Their last quarter was reported on April 24, 2003, about 6 weeks ago, and was great! Revenues, according to NYTimes on the web, increased 51% to $81.3 million with a gross margin of 57% of sales. Operating profit margin grew to 35% of sales, and net income was up 234% (!) to $17.1 million or $.35/share compared to $5.1 million or $.10/share in 2002. These are GREAT numbers.
Checking Morningstar.com, we find revenue at $0.3 million in 1996, up to $7.6 million in 1997, $65.9 million in 1998, $136.5 million in 1999, $165 million in 2000, $192 million in 2001, and $277 million in 2002. Isn't that a NICE progression?
Free cash flow has gradually increased from $7 milion in 2000 to $3 million in 2001 and now $20 million in 2002.
Assets/liabilities is nice as presented in Morningstar with $39.8 million in CASH, enough to pay off current liabilities of $40.3 million. In addition there is $108.3 million in additional current assets and NO long-term debt.
Valuation-wise, not really cheap with a p/e of 31.09. There are 46.09 million shares outstanding.
This stock looks very nice and has done very well..but not dirt-cheap. Bob